Will the Innovative Medicines Initiative really deliver innovative medicines?

The IMI research agenda is based on four areas to overcome research bottlenecks: ^∗Predicting safety – related to evaluating the safety of a compound during the pre-clinical development; predicting efficacy – addresses bottlenecks in the ability to predict how a drug will interact in humans; knowledge management – the more effective utilisation of information and data for predicting safety and efficacy; and education and training – to close existing training gaps in the drug development process. Source: EFPIA.

Schematic representation of the steps involved in the development of a new drug, Source: EFPIA.